BVXV - Bionvax Pharmaceuticals GAAP EPS of -NIS0.02 August, 25 2022 07:45 AM BiondVax Pharmaceuticals Ltd. Biondvax Pharmaceuticals press release ( NASDAQ: BVXV ): Q2 GAAP EPS of -NIS0.02. As of June 30, 2022, BiondVax had cash and cash equivalents of NIS39.5M ($11.3 million) compared to NIS 54.0M as of December 31, 2021. For further details see: Bionvax Pharmaceuticals GAAP EPS of -NIS0.02